High plasma HDL-C is associated with a strong reduction in AD risk (HR 0.4) (Zhu and Parks, 2012), conversely, AD patients have low concentrations of apolipoprotein A-I (ApoA-I), the defining HDL protein (Luo et al., 2017). Here, APOA1 is linked to Alzheimer disease.